› Forums › General Melanoma Community › Ex-Lurker Coming Out
- This topic has 27 replies, 5 voices, and was last updated 10 years, 10 months ago by
JC.
- Post
-
- March 28, 2014 at 4:22 pm
I've been lurking on this Board now and then for the past year, but it's about time I added something to it.
A quick recap of my situation: 66 year old caucasion male with extensive history of sun exposure. Superficial melanoma-in-situ removed from scalp 2006, clean margins, no further workup. Feb 2013 parotid tumor biopsy showed melanoma, otherwise negative PET. March 2013 parotidectomy, neck dissection, 1 of 32 nodes positive. April-May radiation to neck. November – tumor recurrence on neck incision scar, PET shows tumors in neck, leg, lungs, scalp. January 2014 start clinical trial of ipilumimab plus either nivolumab or placebo. Within weeks, all signs and symptoms from tumors resolve. Repeat CT yesterday, results pending.
Late 2013, when things were at their worst, I started writing down some of my thoughts – primarily for my own benefit, to be able to see and re-read what I had been thinking. I shared the blog site with family and a few friends, but don't really have an interest in promoting it. As the site has gained exposure, I have received feedback from some people that the blog helped them in their difficult times with their own challenges (not necessarily melanoma), so I thought I would post the site here, just in case it may be helpful for someone.
daveschronicle.blogspot.com
- Replies
-
-
- March 28, 2014 at 5:19 pm
Thank you 'dvd'…hoping you continue to do well…appreciate your sharing your experience…and your blog
-
- March 28, 2014 at 8:17 pm
The study becomes "unblinded" if there is no clinical effect or my disease progresses. I would then be offered nivolumab if I had been on placebo. In theory, I could receive only ipi X 4 then get 9 months of placebo. All clinical indications, however, strongly suggest I am getting both drugs now.
-
- March 28, 2014 at 8:17 pm
The study becomes "unblinded" if there is no clinical effect or my disease progresses. I would then be offered nivolumab if I had been on placebo. In theory, I could receive only ipi X 4 then get 9 months of placebo. All clinical indications, however, strongly suggest I am getting both drugs now.
-
- March 28, 2014 at 8:17 pm
The study becomes "unblinded" if there is no clinical effect or my disease progresses. I would then be offered nivolumab if I had been on placebo. In theory, I could receive only ipi X 4 then get 9 months of placebo. All clinical indications, however, strongly suggest I am getting both drugs now.
-
- March 28, 2014 at 11:38 pm
Thanks — just got the scan results. This is the first scan since starting the BMS ipi/nivo clinical trial on January 7th. All measurable lesions identified on the previous scan have resolved. Other, minor abnormalities may need to be looked into, but, in general, very good news.
-
- March 28, 2014 at 11:38 pm
Thanks — just got the scan results. This is the first scan since starting the BMS ipi/nivo clinical trial on January 7th. All measurable lesions identified on the previous scan have resolved. Other, minor abnormalities may need to be looked into, but, in general, very good news.
-
- March 28, 2014 at 11:38 pm
Thanks — just got the scan results. This is the first scan since starting the BMS ipi/nivo clinical trial on January 7th. All measurable lesions identified on the previous scan have resolved. Other, minor abnormalities may need to be looked into, but, in general, very good news.
-
- March 28, 2014 at 8:26 pm
Dave,
Thanks for leading us to your blog – I just read the whole thing. I know everyone is different, but you gave me some insight to a few things that may have been going through my husband's mind.
I particularly appreciated your post on statistics. That's a piece of advice lots of us here have received – and given to other melanoma patients and caregivers: don't go with the statistics.
I'm also glad to hear of your experience in the Phase III trial of ipi and nivo. It sounds like at least you are an ipi responder, and perhaps also to nivo. How wonderful!
Will be thinking of you and reading your blog.
~Hazel
-
- March 28, 2014 at 8:26 pm
Dave,
Thanks for leading us to your blog – I just read the whole thing. I know everyone is different, but you gave me some insight to a few things that may have been going through my husband's mind.
I particularly appreciated your post on statistics. That's a piece of advice lots of us here have received – and given to other melanoma patients and caregivers: don't go with the statistics.
I'm also glad to hear of your experience in the Phase III trial of ipi and nivo. It sounds like at least you are an ipi responder, and perhaps also to nivo. How wonderful!
Will be thinking of you and reading your blog.
~Hazel
-
- March 28, 2014 at 8:26 pm
Dave,
Thanks for leading us to your blog – I just read the whole thing. I know everyone is different, but you gave me some insight to a few things that may have been going through my husband's mind.
I particularly appreciated your post on statistics. That's a piece of advice lots of us here have received – and given to other melanoma patients and caregivers: don't go with the statistics.
I'm also glad to hear of your experience in the Phase III trial of ipi and nivo. It sounds like at least you are an ipi responder, and perhaps also to nivo. How wonderful!
Will be thinking of you and reading your blog.
~Hazel
- You must be logged in to reply to this topic.